Sepsis:KnowFromDay1

Dr. Carl Flatley, Founder and former Chairman of The Sepsis Alliance, discusses the movement in New York to adopt “Rory’s Regulations,” new legislation that mandates all hospitals in the state adopt and practice an evidence-based protocol for sepsis. Dr. Flatley will discuss the tragedy that sparked the New York movement and what it means for healthcare providers in New York and across the United States.

Part 2 of 2 featuring Dr. Mark Oltermann, M.D. director of the Medical ICU at John Peter Smith Hospital, a 430-bed level 1 trauma center in Fort Worth, Texas. He discusses the coming sepsis boom and the available, but underutilized diagnostic tools that could advert it

Part 1 of 2 featuring Dr. Mark Oltermann, M.D. director of the Medical ICU at John Peter Smith Hospital, a 430-bed level 1 trauma center in Fort Worth, Texas. He discusses the coming sepsis boom and the available, but underutilized diagnostic tools that could advert it.

Part 2 of 2 featuring Dr. Charles Cairns, Professor and Chair of Emergency Medicine at the University of North Carolina School of Medicine. Dr. Cairns discusses both PCT and Lactate as markers for sepsis and provides expert insight into their use.

Part 1 of 2 featuring Dr. Charles Cairns, Professor and Chair of Emergency Medicine at the University of North Carolina School of Medicine. Dr. Cairns discusses both PCT and Lactate as markers for sepsis and provides expert insight into their use.

Carl Flatley tells the personal stories that resulted in the foundation of the Sepsis Alliance and explains the organization’s mission to help save lives by increasing awareness of this deadly condition.

This final episode with Kirsten Springer, RN, CCRN on the use of procalcitonin from the critical care nurse perspective in the ED contains the QandA portion of her presentation.

Part 2 of 3 featuring Kirsten Springer, RN, CCRN on the use of procalcitonin from the critical care nursing perspective. Includes why PCT is a useful biomarker; a case review; and information on a successful surviving sepsis campaign.

Part 1 of 3 featuring Kirsten Springer, RN, CCRN, discusses the role of the critical care nurse in the ED, standardization of care practices, diagnosis, and important sepsis initiatives.

This final episode with Dr. Rakesh Engineer on the use of procalcitonin in risk stratification of sepsis syndromes in the emergency department.

Part 2 of 3 featuring Dr. Rakesh Engineer on the use of procalcitonin in risk stratification of sepsis syndromes in the emergency department, delving further into the use of PCT as a useful biomarker for this purpose.

Part 1 of 3 featuring Dr. Rakesh Engineer on the use of procalcitonin in risk stratification of sepsis syndromes in the emergency department, covering definition and epidemiology of sepsis to characteristics of a procalcitonin as a useful biomarker.

In the final of three episodes, member of Morton Plant Hospital conclude their discussion on the integration of procalcitonin by outlining how the hospital system adopted procalcitonin into their sepsis protocol.

In Part 2 of 3, the Morton Plant Hospital team how the decision is made to run a procalcitonin test based on the hospital’s sepsis alert protocol and how the test is used when a patient shows signs of potential infection and sepsis.

This episode features members of Morton Plant Hospital discussing the integration of procalcitonin into the Florida-based hospital’s sepsis alert protocol. Perspectives from three stakeholders – critical care, nursing and clinical lab – are included.